Screener
Apogee Therapeutics, Inc. APGE Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Apogee Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
FAQ
- What is Apogee Therapeutics, Inc.'s current ratio?
- Apogee Therapeutics, Inc. (APGE) reported current ratio of 32.6× in Q1 2026.
- How has Apogee Therapeutics, Inc.'s current ratio changed year-over-year?
- Apogee Therapeutics, Inc.'s current ratio increased by 105.9% year-over-year, from 15.8× to 32.6×.
- What is the long-term trend for Apogee Therapeutics, Inc.'s current ratio?
- Over 3 years (2022 to 2025), Apogee Therapeutics, Inc.'s current ratio has grown at a 20.4% compound annual growth rate (CAGR), from 15.2× to 26.6×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Apogee Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude